Christian Angermayer

Angermayer shows a public interest in human enhancement and life extension, especially through Enhanced Games and related 'humanmaxxing' discussion, but the provided evidence does not show a concrete, durable vision specifically for ending aging, reversing biological decline, or materially extending healthy lifespan. The vision signal is adjacent and promotional rather than a clear longevity thesis with mechanisms, timelines, risks, or repeated theory commitments.

The evidence contains no citation metrics, authored papers, clinical trials, or independently corroborated scientific achievements. Self-published X/profile evidence only indicates biotech/psychedelics investing and company affiliation, which is insufficient to score scientific impact as a result dimension.

No evidence of direct scientific output; available evidence portrays him as an investor/founder rather than a scientist.

The dimension applies because Angermayer presents himself as an investor and founder, including in biotech and human enhancement, but the provided evidence contains no disclosed longevity-specific investments, donations, amounts, recurring commitments, or independently corroborated capital deployment. Self-published posts suggest interest in enhancement and life extension-adjacent ventures, but not enough to substantiate meaningful longevity capital deployed.

Angermayer shows a coherent, high-risk strategic thesis around human enhancement as a commercial category, linking enhanced sports, telehealth distribution, psychedelics, biohacking, weight loss, sleep, appearance, and life extension. The evidence supports pattern coherence and contrarian category selection, especially Enhanced Games/Live Enhanced and atai/AtaiBeckley. However, the record here is mostly self-published, recent, and thin on concrete investment amounts, timing, counterfactual impact, or field-opening outcomes, so the score is moderate rather than high.

The dimension applies because the evidence includes claims of founding organizations and platforms, but the provided record contains no independent or primary corroboration that Angermayer created longevity-specific organizations, programs, communities, protocols, or funding paths. The only field-building signals are self-published X/profile claims around Apeiron, ATAI, Enhanced Games, and enhancement discourse, which cannot justify a score above 5 and are only loosely tied to longevity.

There is credible but narrow evidence of public conviction: Angermayer openly associates himself with biohacking, life extension, human enhancement, and the controversial Enhanced Games under his own name. This supports contrarian/public-defense bravery, but the record here is mostly self-published promotion and does not show major personal downside, sustained criticism endured, financial magnitude relative to capacity, or actual self-experimentation.

The dimension applies because Angermayer is publicly positioning longevity-adjacent work around human enhancement platforms, public-market vehicles, telehealth, sports spectacle, and psychedelics. That suggests potential multiplier effects through capital formation, public attention, and commercialization beyond direct work. However, the provided evidence is almost entirely self-published or reposted social content, with no independent or primary corroboration of actual field-building outcomes, organizations, investments, follow-on projects, or talent/capital mobilization. Under the independence gate, this cannot justify a score above 5.